A Health Services Approach for the Evaluation of Innovative Pharmaceutical and Biotechnology Products

This publication has 47 references indexed in Scilit:

• Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis Syndrome
  JAMA, 1995
• Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis
  New England Journal of Medicine, 1994
• Treatment of Septic Shock with Human Monoclonal Antibody HA-1A
  Annals of Internal Medicine, 1994
• Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome
  JAMA, 1994
• A Decision Analysis of Alternative Treatment Strategies for Clinically Localized Prostate Cancer
  Published by American Medical Association (AMA) ,1993
• Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions
  New England Journal of Medicine, 1992
• A Model for Evaluating the Cost-Effectiveness of Cholesterol-Lowering Treatment
  International Journal of Technology Assessment in Health Care, 1992
• A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative Sepsis
  JAMA, 1991
• Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against Endotoxin
  New England Journal of Medicine, 1991
• A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic Shock
  New England Journal of Medicine, 1987